title: Use of Corticosteroids in the management of Idiopathic Pulmonary Haemosiderosis: Do we have enough evidence.
abstract: Idiopathic Pulmonary Haemosiderosis (IPH) is a rare disease commonly affecting the paediatric population with approximately 500 globally reported cases in the literature. The disease usually presentswith a symptom triad consisting of ferropenic anaemia, cough with haemoptysis and diffuse bilateral alveolar infiltrates. Therapeutic options for this disorder are not only limited but also not fully effective. Moreover, corticosteroids remain the mainstay of IPH treatment. This communication reviews the available evidence in support of corticosteriod usage in the treatment of IPH. We conclude that the use of corticosteroid in IPH treatment is unfathomed and demands further investigation.
authors.affiliation: Ammara Mushtaq, Final Year Medical Student, Dow Medical College, Dow University of Health Sciences, Karachi - Pakistan.
authors.forename: Ammara
authors.initials: A
authors.lastname: Mushtaq
authors.affiliation: Subika Khatoon, Final Year Medical Student, Dow Medical College, Dow University of Health Sciences, Karachi - Pakistan.
authors.forename: Subika
authors.initials: S
authors.lastname: Khatoon
authors.affiliation: Dr. Muhammad Asif Qureshi, MBBS, PhD Assistant Professor Immunology, Dow Medical College, Dow University of Health Sciences, Karachi - Pakistan.
authors.forename: Muhammad Asif
authors.initials: MA
authors.lastname: Qureshi
keywords: Corticosteroids; Idiopathic Pulmonary Haemosiderosis